342.35
price down icon1.13%   -3.93
after-market Handel nachbörslich: 342.00 -0.35 -0.10%
loading
Schlusskurs vom Vortag:
$346.28
Offen:
$347.01
24-Stunden-Volumen:
1.32M
Relative Volume:
0.61
Marktkapitalisierung:
$77.09B
Einnahmen:
$194.82B
Nettoeinkommen (Verlust:
$5.53B
KGV:
14.00
EPS:
24.4514
Netto-Cashflow:
$3.77B
1W Leistung:
-1.84%
1M Leistung:
+4.89%
6M Leistung:
-20.16%
1J Leistung:
-18.30%
1-Tages-Spanne:
Value
$340.04
$349.02
1-Wochen-Bereich:
Value
$335.10
$355.79
52-Wochen-Spanne:
Value
$273.71
$458.73

Elevance Health Inc Stock (ELV) Company Profile

Name
Firmenname
Elevance Health Inc
Name
Telefon
(800) 331-1476
Name
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Name
Mitarbeiter
104,200
Name
Twitter
Name
Nächster Verdiensttermin
2025-10-21
Name
Neueste SEC-Einreichungen
Name
ELV's Discussions on Twitter

Vergleichen Sie ELV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Healthcare Plans icon
ELV
Elevance Health Inc
342.35 76.96B 194.82B 5.53B 3.77B 24.45
Healthcare Plans icon
UNH
Unitedhealth Group Inc
362.50 326.45B 422.82B 22.09B 25.27B 23.09
Healthcare Plans icon
CVS
Cvs Health Corp
81.93 102.82B 386.46B 4.49B 4.78B 3.5841
Healthcare Plans icon
CI
Cigna Group
301.78 81.43B 261.22B 5.40B 3.94B 18.31
Healthcare Plans icon
HUM
Humana Inc
290.65 35.04B 123.11B 1.58B 2.44B 13.03

Elevance Health Inc Stock (ELV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-14 Eingeleitet Goldman Neutral
2025-07-21 Herabstufung Argus Buy → Hold
2025-07-18 Herabstufung Leerink Partners Outperform → Market Perform
2025-04-15 Herabstufung Robert W. Baird Outperform → Neutral
2025-03-17 Hochstufung Argus Hold → Buy
2025-01-22 Herabstufung Stephens Overweight → Equal-Weight
2024-10-18 Herabstufung Argus Buy → Hold
2024-07-18 Herabstufung BofA Securities Buy → Neutral
2024-06-24 Eingeleitet Morgan Stanley Overweight
2024-05-30 Eingeleitet Robert W. Baird Outperform
2024-03-06 Eingeleitet Barclays Overweight
2023-07-12 Herabstufung Wolfe Research Outperform → Peer Perform
2023-04-27 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-04-21 Eingeleitet Cantor Fitzgerald Overweight
2023-03-28 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2022-09-09 Hochstufung BofA Securities Neutral → Buy
2022-08-22 Hochstufung SVB Leerink Mkt Perform → Outperform
Alle ansehen

Elevance Health Inc Aktie (ELV) Neueste Nachrichten

pulisher
Oct 24, 2025

How Elevance Health Inc. (A58) stock correlates with oil markets2025 Major Catalysts & Smart Money Movement Alerts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

How Elevance Health Inc. stock reacts to Fed rate cutsWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Advanced analytics toolkit walkthrough for Elevance Health Inc.Market Trend Summary & Community Verified Trade Signals - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Trend analysis for Elevance Health Inc. this weekJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Has Elevance Health Inc. formed a bullish divergenceWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Elevance to penalize facilities for out-of-network providers - Modern Healthcare

Oct 24, 2025
pulisher
Oct 24, 2025

Bernstein Adjusts Elevance Health Price Target to $412 From $420 - MarketScreener

Oct 24, 2025
pulisher
Oct 24, 2025

Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Is Elevance Health Inc. stock trading at a premium valuation2025 Market Trends & Expert Curated Trade Ideas - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Elevance Health: Q3 Figures Underscore Slow But Steady Recovery (NYSE:ELV) - Seeking Alpha

Oct 24, 2025
pulisher
Oct 24, 2025

What momentum indicators show for Elevance Health Inc. stock - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Why Elevance Health Inc. (A58) stock attracts wealthy investorsGlobal Markets & High Accuracy Buy Signal Tips - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Will Elevance Health Inc. stock outperform global peersJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ - Stocktwits

Oct 24, 2025
pulisher
Oct 23, 2025

Wells Fargo Reaffirms Their Buy Rating on Elevance Health (ELV) - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

Centene And Oscar Health Stocks Sink After Molina Warning - Benzinga

Oct 23, 2025
pulisher
Oct 23, 2025

TD Cowen Raises Price Target for Elevance Health (ELV) to $380 | - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

TD Cowen Adjusts Price Target on Elevance Health to $380 From $330, Maintains Buy Rating - MarketScreener

Oct 23, 2025
pulisher
Oct 23, 2025

Molina tumbles on profit forecast cut, drags broader health insurance stocks - Reuters

Oct 23, 2025
pulisher
Oct 23, 2025

Elevance Health (ELV) Gets a Buy from Truist Financial - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

Is Elevance Health Inc. stock supported by strong cash flowsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Elevance Health (ELV) Announces Fiscal Q3 2025 Results - Insider Monkey

Oct 22, 2025
pulisher
Oct 22, 2025

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Social News XYZ

Oct 22, 2025
pulisher
Oct 22, 2025

Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance Health Named Top Dividend Stock With Insider Buying and 1.96% Yield (ELV) - Nasdaq

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance CFO: 2026 Should Mark ‘The Trough’ For Medicaid Margins - HCI Innovation Group

Oct 22, 2025
pulisher
Oct 22, 2025

Leerink Partners Adjusts Price Target on Elevance Health to $350 From $310, Maintains Market Perform Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Goldman Sachs Adjusts Price Target on Elevance Health to $331 From $343, Maintains Neutral Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Barclays Adjusts Price Target on Elevance Health to $385 From $395, Maintains Overweight Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Barclays Lowers Price Target for Elevance Health (ELV) to $385 | ELV Stock News - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance: Checking Out The Q3 Test Results (NYSE:ELV) - Seeking Alpha

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance Health (ELV) Margin Decline Challenges Bullish Earnings Growth Narratives - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Historical volatility pattern of Elevance Health Inc. visualized2025 Macro Impact & Low Risk Entry Point Tips - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance Health Reports Strong Q3 2025 Revenue Growth - TipRanks

Oct 22, 2025
pulisher
Oct 22, 2025

Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus

Oct 22, 2025
pulisher
Oct 21, 2025

Elevance Health: Q3 Earnings Snapshot - Stamford Advocate

Oct 21, 2025
pulisher
Oct 21, 2025

Visual trend scoring systems applied to Elevance Health Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... By GuruFocus - Investing.com Canada

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health execs expect Medicaid costs to rise in 2026 - Fierce Healthcare

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Why Is Elevance Health Stock Falling Tuesday?Elevance Health (NYSE:ELV) - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance health unfazed by 'elevated' commercial group medical costs - BenefitsPRO

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership - Zacks Investment Research

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Stro - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance Health, Inc. Declares Fourth Quarter Dividend, Payable on December 19, 2025 - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

What’s next for Elevance Health Inc. stock priceMarket Growth Review & Safe Swing Trade Setups - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Elevance flags higher costs in Medicaid business in 2026, shares retreat - Reuters

Oct 21, 2025

Finanzdaten der Elevance Health Inc-Aktie (ELV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
healthcare_plans CI
$301.78
price down icon 1.08%
healthcare_plans CVS
$81.93
price up icon 1.06%
healthcare_plans HUM
$290.65
price down icon 0.22%
healthcare_plans CNC
$34.07
price down icon 0.84%
healthcare_plans MOH
$163.32
price up icon 1.44%
Kapitalisierung:     |  Volumen (24h):